Utilizing anti-TNC antibodies makes cells more sensitive to T cell-mediated tumor killing and enhances the anti-tumor efficacy of PD-1 blockade in autophagy-deficient TNBC tumors (32). This evidence concerns the gene PDCD1 and neoplasm.